{"version":"1.0","type":"link","title":"Beyond progression-free survival (PFS): time to next treatment (TTNT) as a patient-centered metric of clinical benefit in chronic lymphocytic leukemia (CLL).","author_name":"Molica S 외","author_url":"https://prs-insight.online/author/Molica%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/85695","thumbnail_width":1200,"thumbnail_height":630}